SCN1A and encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy: All 18 Dravet syndrome patients were identified with mutations in SCN1A gene, and 14 (77.8%) patients showed a good response to KD at 3 months since initiation of KD.